Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Sales | 31,609 | 69,409 | 41,675 | 50,992 | 41,014 |
| Cost of Goods | 4,194 | 3,701 | 3,576 | 3,672 | 3,562 |
| Gross Profit | 27,415 | 65,708 | 38,099 | 47,320 | 37,452 |
| Operating Expenses | 158,237 | 157,890 | 137,411 | 139,740 | 151,809 |
| Operating Income | -130,628 | -91,481 | -98,736 | -91,748 | -113,795 |
| Interest Expense | 3,812 | 3,833 | 1,914 | 0 | 494 |
| Other Income | 4,396 | 3,993 | 4,496 | 5,997 | 7,256 |
| Pre-tax Income | -130,044 | -91,321 | -96,154 | -85,751 | -107,033 |
| Net Income Continuous | -130,044 | -91,321 | -96,154 | -85,751 | -107,033 |
| Net Income | $-130,044 | $-91,321 | $-96,154 | $-85,751 | $-107,033 |
| EPS Basic Total Ops | -0.93 | -0.66 | -0.72 | -0.66 | -0.82 |
| EPS Basic Continuous Ops | -0.93 | -0.66 | -0.72 | -0.66 | -0.82 |
| EPS Diluted Total Ops | -0.93 | -0.66 | -0.72 | -0.66 | -0.82 |
| EPS Diluted Continuous Ops | -0.93 | -0.66 | -0.72 | -0.66 | -0.82 |
| EBITDA(a) | $-122,675 | $-83,311 | $-91,238 | $-84,297 | $-106,960 |